(Q48725493)

English

Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.

scientific article published on 16 October 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/26472682

Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/26472682

0 references

pathophysiology

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

ejection fraction

1 reference

based on heuristic

inferred from title

Hans-Peter Brunner-La Rocca

7

object named as

Hans-Peter Brunner-La Rocca

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

author name string

Sandra Sanders-van Wijk

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/26472682

Vanessa van Empel

2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/26472682

Nasser Davarzani

3

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/26472682

Micha T Maeder

4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/26472682

Rolf Handschin

5

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/26472682

Matthias E Pfisterer

6

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/26472682

TIME-CHF investigators

8

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/26472682

publication date

16 October 2015

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/26472682

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/26472682

17

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/26472682

10

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/26472682

1006-1014

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/26472682

Heart failure with normal left ventricular ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Integration of exercise evaluation into the algorithm for evaluation of patients with suspected heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Biomarkers of heart failure with normal ejection fraction: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Inflammatory pathways in patients with heart failure and preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Insulin resistance and inflammatory activation in older patients with systolic and diastolic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Predictive value of high sensitivity CRP in patients with diastolic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Prognostic value of cystatin C on admission in heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Novel biomarkers for heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Emerging biomarkers in heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Minor myocardial damage is a prevalent condition in patients with acute heart failure syndromes and preserved systolic function with long-term prognostic implications: a report from the CIAST-HF (Collaborative Italo-Argentinean Study on cardiac Trop

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Tumor necrosis factor-alpha and mortality in heart failure: a community study

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

21 January 2018

Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

7 January 2021

based on heuristic

inferred from DOI database lookup

Natriuretic peptides

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

7 January 2021

based on heuristic

inferred from DOI database lookup

Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical characteristics and prognostic influence of renal dysfunction in heart failure patients with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the effect of anemia on in-hospital mortality in patients with versus without preserved left ventricular ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.414

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJHF.414

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/26472682

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/26472682

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48725493&oldid=1866805227"